Kruppel-Like Factor 2 Regulates Endothelial Barrier Function
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 30 (10) , 1952-1959
- https://doi.org/10.1161/atvbaha.110.211474
Abstract
Objective— A central function of the endothelium is to serve as a selective barrier that regulates fluid and solute exchange. Although perturbation of barrier function can contribute to numerous disease states, our understanding of the molecular mechanisms regulating this aspect of endothelial biology remains incompletely understood. Accumulating evidence implicates the Kruppel-like factor 2 (KLF2) as a key regulator of endothelial function. However, its role in vascular barrier function is unknown. Methods and Results— To assess the role of KLF2 in vascular barrier function in vivo, we measured the leakage of Evans blue dye into interstitial tissues of the mouse ear after treatment with mustard oil. By comparison with KLF2 +/+ mice, KLF2 +/− mice exhibited a significantly higher degree of vascular leak. In accordance with our in vivo observation, adenoviral overexpression of KLF2 in human umbilical vein endothelial cells strongly attenuated the increase of endothelial leakage by thrombin and H 2 O 2 as measured by fluorescein isothiocyanate dextrans (FITC-dextran) passage. Conversely, KLF2 deficiency in human umbilical vein endothelial cells and primary endothelial cells derived from KLF2 +/− mice exhibited a marked increase in thrombin and H 2 O 2 -induced permeability. Mechanistically, our studies indicate that KLF2 confers barrier-protection via differential effects on the expression of key junction protein occludin and modification of a signaling molecule (myosin light chain) that regulate endothelial barrier integrity. Conclusion— These observations identify KLF2 as a novel transcriptional regulator of vascular barrier function.Keywords
This publication has 52 references indexed in Scilit:
- Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotypeCardiovascular Research, 2009
- Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression via Induction of Krüppel-Like Transcription FactorsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Molecular mechanisms of endothelial hyperpermeability: implications in inflammationExpert Reviews in Molecular Medicine, 2009
- Occludin oligomeric assemblies at tight junctions of the blood–brain barrier are altered by hypoxia and reoxygenation stressJournal of Neurochemistry, 2009
- TGF-β Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult MicrovasculaturePLOS ONE, 2009
- Hemizygous Deficiency of Krüppel-Like Factor 2 Augments Experimental AtherosclerosisCirculation Research, 2008
- Klf4 and corticosteroids activate an overlapping set of transcriptional targets to acceleratein uteroepidermal barrier acquisitionProceedings of the National Academy of Sciences, 2006
- KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endotheliumBlood, 2006
- LKLF: A Transcriptional Regulator of Single-Positive T Cell Quiescence and SurvivalScience, 1997
- Involvement of rho in GTPγS‐induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activityFEBS Letters, 1995